Japan· JP-2499408D1028
メカセルミン（遺伝子組換え）
A medicinal product containing メカセルミン（遺伝子組換え）, registered in Japan by オーファンパシフィック, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- メカセルミン（遺伝子組換え）
- Manufacturer
- オーファンパシフィック
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
メカセルミン（遺伝子組換え） in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGUNA-IGFGuna spa
- CanadaINCRELEXIPSEN BIOPHARMACEUTICALS CANADA INC
- CzechiaINCRELEXEsteve Pharmaceuticals S.A., Barcelona
- SpainINCRELEX 10 mg/ml SOLUCION INYECTABLEEsteve Pharmaceuticals S.A.
- FinlandIncrelexEsteve Pharmaceuticals, S.A
- FranceINCRELEX 10 mg/ml, solution injectableESTEVE PHARMACEUTICALS (ESPAGNE)
- United KingdomIncrelex 40mg/4ml solution for injection vialsEsteve Pharmaceuticals Ltd
- BelgiumIncrelex 10 mg/mlEsteve Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Increlex
- Liechtenstein · Increlex
- Norway · Increlex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d6f361f-39d0-4fdc-9976-fe0a956f1bd7 GET /v1/drugs/2d6f361f-39d0-4fdc-9976-fe0a956f1bd7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０ｍｇ１瓶（溶解液付）",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2499408D1028",
"category": "注射薬",
"price_yen": 53252,
"generic_name": "メカセルミン（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "2499",
"transitional_expiry": null
}See everything about メカセルミン（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.